By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003



Drug Discovery

Company News
Achillion (ACHN) Announces Upcoming Presentations At The International Liver Congress 2015 (EASL) 4/8/2015 8:15:40 AM
Should Gilead (GILD) Feel Threatened by Achillion (ACHN)'s Next-Generation Hep C Drug? 4/2/2015 6:34:05 AM
Achillion (ACHN) Reports 2014 Fourth Quarter And Year-End Financial Results 3/5/2015 7:38:04 AM
Achillion (ACHN) Announces Closing Of Public Offering Of Common Stock 2/19/2015 7:51:22 AM
Achillion (ACHN) Announces Pricing Of Public Offering Of Common Stock 2/12/2015 7:25:31 AM
Achillion (ACHN), Gilead (GILD)'s Drug Cocktail Cures Hepatitis C in Six Weeks 2/9/2015 6:05:56 AM
Achillion Pharmaceuticals, Inc. (ACHN) To Present At Two Upcoming Investor Conferences 2/6/2015 10:19:58 AM
Achillion Pharmaceuticals, Inc. (ACHN) Shows Potential For "Best-In-Disease" HCV Regimen - 100% SVR4 Following A Dual 6-Week ACH-3102-Based Regimen And Separately A 4.8 Log10 Reduction With ACH-3422 12/22/2014 6:19:04 AM
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure 12/22/2014 6:18:24 AM
Why Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Are Keeping An Eye On Achillion Pharmaceuticals, Inc. (ACHN) 12/12/2014 6:15:51 AM